Pregnancy in lupus

Current Opinion in Rheumatology

Volumn 11, Issue 5, 1999, Pages 348-351

  Meng, Charis ^a   Lockshin, Michael ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHILDHOOD MORTALITY; CONGENITAL HEART BLOCK; DISEASE ACTIVITY; FEMALE; FETUS WASTAGE; HUMAN; KIDNEY DISEASE; MATERNAL HYPERTENSION; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; REVIEW; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULAR DISEASE;

FEMALE; HUMANS; INFANT, NEWBORN; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 0032750487     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199909000-00004     Document Type: Review

References (19)

1. Lockshin, M: Pregnancy does not cause systemic lupus erythematosus to worsen. Arthritis Rheum 1989, 32:665-70
2. Tincani A, Faden D, Tarantini M, Lojacono A, Tanzi P, Gastaldi A, DiMario C, Spatola L, Cataneo R, Balestrieri G: Systemic lupus erythematosus and pregnancy: a prospective study. Clin Exp Rheumatol 1992, 10:439-46
3. Petri M, Howard D, Repke J: Frequency of lupus flare in pregnancy, the Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 1991, 34:1538-45
4. Johns KR, Morand EF, Littlejohn GO: Pregnancy outcome in systemic lupus erythematosus (SLE): a review of 54 cases. Aust NZ J Med 1998, 28:18-22
5. Rahman P, Gladman D, Urowitz M: Clinical predictors of fetal outcome in systemic lupus erythematosus. J Rheumatol 1998, 25:1526-1530
6. Mavragani CP, Dafni UG, Tzioufas AG, Moutsopoulos HM: Pregnancy outcome and anti-Ro/SSA in autoimmune diseases: a retrospective cohort study. Br J Rheumatol 1998, 37:740-745
7. Magid M, Kaplan C, Sammaritano L, Peterson M, Druzin M, Lockshin M: Placental pathology in systemic lupus erythematosus: a prospective study. Am J Obstet Gynecol 1998, 179:226-234. Describes of placental pathology and clinical correlates in SLE and APLS patients, and differentiates the separate effects of the two disease entities.
8. 8 Buyon J, Hiebert R, Copel J, Craft J, Friedman D, Katholi M, Lee L, Provost T, Reichlin M, Rider L, Rupel A, Saleeb S, Weston W, Skovron M: Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. JACC 1998, 31:658-666. Population taken from registry of well documented cases of neonatal lupus.
9. Kelley W, Harris E, Ruddy S, Sledge C: Neonatal lupus. In Textbook of Rheumatology, 5th edition. Philadelphia: WB Saunders Co. 1997, 1052
10. Viana V, Garcia S, Nascimento J, Elkon K, Brot N, Campos de Carvalho A, Bonfa E: induction of in vitro heart block is not restricted to affinity purified anti-52kDa Ro/SSA antibody from mothers of children with neonatal lupus. Lupus 1998, 7:141-147
11. Siren M, Julkunen H, Kaaja R, Kurki P, Koskimies S: Role of HLA in congenital heart block: susceptibility alleles in mothers. Lupus 1999, 8:52-59
12. Siren M, Julkunen H, Kaaja R, Ekblad H, Koskimies S: Role of HLA in congenital heart block: susceptibility alleles in children. Lupus 1999, 8:60-67
13. Julkunen H, Kaaja R, Siren M, Mack C, McCready S, Holthofer H, Kurki P, Maddison P: Immune-mediated congenital heart block (CHB): identifying and counseling patients at risk for having children with CHB. Sem Arthritis Rheum 1998, 28:97-106. Included 3 sets of controls with SLE, primary Sjögren's and healthy mothers
14. Day H, Thiagarajan P, Ahn C, Reveille J, Tinker K, Arnett F: Autoantibodies to (2-glycoprotein I in systemic lupus erythematosus and primary antiphosphlipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. J Rheumatol 1998, 25:667-674. Defined the sensitivities, specificities and predictive values of antiB2GP-I antibodies compared to standard aPL and LAC assays.
15. Sammaritano L, Gharavi A, Soberano C, Levy R, Lockshin M. Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein. Journal of Clinical Immunology 1992, 12:27-35
16. Rand J, Wu X, Andree H, Ross J, Rusinova E, Gascon-Lema M, Calandri C, Harpel P: Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a "lupus procoagulant" phenomenon. Blood 1998, 92:1652-1660. Insight into mechanism of antiphosholipid antibody mediated coagulation
17. Simpson J, Carson S, Chesney C, Conley M, Metzger B, Aarons J, Holmes L, Jovanovic-Peterson L, Knopp R, Mills J: Lack of association between antiphospholipid antibodies and first-trimester spontaneous abortion: prospective study of pregnancies detected within 21 days of conception. Fertility and Sterility 1998, 69:814-819. Pregnancy clearly defined in their population.
18. Balasch J, Creus M, Fabregues F, Civico S, Reerter J, Carmon F, Tassies D, Vanrell J: Antiphospholipid antibodies and the outcome of pregnancy after the first in-vitro fertilization and embryo transfer cycle. Hum Reprod 1998, 13:1180-1183
19. 1 in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization. Am J Reprod Immunol 1998, 40:74-82